This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. It gives an insider's account of the pharmaceutical industry drug discovery process, the very real costs of misperceptions about the industry, the high stakes--both economic and scientific--of developing drugs, the triumphs that come when new compounds reach the market and save lives, and the despair that follows when new compounds fail. In the book, John LaMattina, former president of Pfizer Global Research and Development, weaves themes critical to a vital drug discovery environment in the context. This is a story that Dr. LaMattina is uniquely qualified to tell.
Keywords: pharmaceutical; hate big; perspective; insiders; industry; pharma; easy; money; lot; drugs; pharmas incentive; big; income; society; argue; generate; antithetical; needs; person; accomplishments; reasonable; industrys; infectious, Pharmacology & Pharmaceutical Medicine, Biochemistry (Chemical Biology), Pharmacology & Pharmaceutical Medicine, Biochemistry (Chemical Biology)